Yngvar H.
- Country
- Norway
- Department
- Medisinsk Klinikk
Research Overview
Data & Insights
Has run more than one trial at 0 of 48 partner sites.
Specializations
Hematologic Malignancies
Yngvar Haaskjold conducts research on blood‑derived cancers, emphasizing innovative therapeutic strategies.
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Mantle Cell Lymphoma
Focus includes targeted agents, immunotherapy, and transplantation approaches.
Solid Tumor Oncology
Investigation of therapeutic options for a broad spectrum of solid cancers is a core activity.
- Non‑Small Cell Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Renal Cell Carcinoma
- Hepatocellular Carcinoma
Efforts target molecularly defined subgroups and combination regimens.
Neurological and Neurodegenerative Disorders
Research addresses diseases of the central and peripheral nervous systems.
- Alzheimer’s disease
- Amyotrophic Lateral Sclerosis
- Multiple Sclerosis
- Glioblastoma
- Neuroblastoma
Therapeutic focus includes disease‑modifying agents and novel delivery methods.
Cardiovascular and Metabolic Diseases
Clinical work encompasses heart, vascular, and metabolic health conditions.
- Atrial Fibrillation
- Chronic Heart Failure
- Type 1 Diabetes
- Obesity
- Takotsubo Syndrome
Studies evaluate anticoagulation, metabolic control, and cardioprotective therapies.
Autoimmune and Inflammatory Disorders
Investigation of immune‑mediated diseases guides therapeutic innovation.
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Systemic Lupus Erythematosus
- Immune Thrombocytopenia
- Thyroid Eye Disease
Approaches include biologics, targeted small molecules, and therapeutic monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.